In today’s session HCP, Inc. (HCP) registered an unusually high (3,318) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the November, 2016 call, expecting serious HCP increase. With 3,318 contracts traded and 3534 open interest for the Nov, 16 contract, it seems this is a quite bullish bet. The option with symbol: HCP161118C00035000 closed last at: $0.45 or 52.6% down. HCP, Inc. (NYSE:HCP) has risen 3.64% since March 29, 2016 and is uptrending. It has outperformed by 0.17% the S&P500.
Analysts await HCP, Inc. (NYSE:HCP) to report earnings on November, 1. They expect $0.71 earnings per share, down 10.13% or $0.08 from last year’s $0.79 per share. HCP’s profit will be $335.24 million for 12.02 P/E if the $0.71 EPS becomes a reality. After $0.74 actual earnings per share reported by HCP, Inc. for the previous quarter, Wall Street now forecasts -4.05% negative EPS growth.
HCP, Inc. (NYSE:HCP) Ratings Coverage
Out of 14 analysts covering HCP (NYSE:HCP), 0 rate it a “Buy”, 5 “Sell”, while 9 “Hold”. This means 0 are positive. $41 is the highest target while $30 is the lowest. The $35.18 average target is 3.05% above today’s ($34.14) stock price. HCP has been the topic of 24 analyst reports since September 8, 2015 according to StockzIntelligence Inc. Bank of America upgraded the stock to “Neutral” rating in Tuesday, October 4 report. The stock of HCP, Inc. (NYSE:HCP) has “Neutral” rating given on Wednesday, March 16 by UBS. The firm has “Underweight” rating by Barclays Capital given on Wednesday, January 6. The stock of HCP, Inc. (NYSE:HCP) has “Neutral” rating given on Tuesday, March 15 by JP Morgan. RBC Capital Markets maintained the stock with “Underperform” rating in Friday, November 6 report. The firm earned “Hold” rating on Tuesday, September 8 by Evercore. UBS maintained it with “Neutral” rating and $38 target price in Tuesday, August 23 report. The company was maintained on Thursday, March 10 by Barclays Capital. The stock of HCP, Inc. (NYSE:HCP) has “Neutral” rating given on Wednesday, August 24 by Citigroup. The stock of HCP, Inc. (NYSE:HCP) has “Underperform” rating given on Tuesday, July 26 by Raymond James.
According to Zacks Investment Research, “Health Care Property Investors, Inc. is a real estate investment trust. The company invests in health care related real estate located throughout the United States, including long-term care facilities, congregate care and assisted living facilities, acute care and rehabilitation hospitals, medical office buildings, physician group practice clinics and psychiatric facilities.”
Insitutional Activity: The institutional sentiment increased to 0.92 in Q2 2016. Its up 0.13, from 0.79 in 2016Q1. The ratio is positive, as 55 funds sold all HCP, Inc. shares owned while 208 reduced positions. 65 funds bought stakes while 177 increased positions. They now own 416.03 million shares or 2.10% less from 424.94 million shares in 2016Q1.
Orleans La last reported 1.7% of its portfolio in the stock. Adage Gp Ltd Limited Liability Company accumulated 0.07% or 697,743 shares. Ig last reported 0.04% of its portfolio in the stock. Manchester Cap Limited accumulated 0% or 500 shares. Jfs Wealth Advsrs Ltd Liability Company accumulated 694 shares or 0.01% of the stock. Bnp Paribas Invest Prtn has 0.31% invested in the company for 1.03M shares. Alps Advisors Incorporated last reported 0.02% of its portfolio in the stock. Walleye Trading reported 22,000 shares or 0.01% of all its holdings. Hancock Holdings has 6,615 shares for 0.01% of their US portfolio. Parametric Associate Llc last reported 0.03% of its portfolio in the stock. Texas Permanent School Fund last reported 151,543 shares in the company. Da Davidson And accumulated 77,076 shares or 0.08% of the stock. Cohen And Steers Inc has invested 3.72% of its portfolio in HCP, Inc. (NYSE:HCP). Quantitative Management has 0.15% invested in the company for 91,400 shares. Davidson Inv Advisors last reported 0.01% of its portfolio in the stock.
Insider Transactions: Since May 9, 2016, the stock had 0 buys, and 5 sales for $878,078 net activity. Kowalske Darren A had sold 2,250 shares worth $88,202. 3,000 shares were sold by Kirby Thomas D, worth $120,725 on Wednesday, September 7. $9,587 worth of HCP, Inc. (NYSE:HCP) was sold by Hsiao Kai on Monday, May 9. 9,000 HCP, Inc. (NYSE:HCP) shares with value of $355,177 were sold by Young Kendall K. The insider Bergschneider Jonathan M. sold $304,387.
HCP, Inc. is a self-administered real estate investment trust (REIT). The company has a market cap of $16.12 billion. The Firm invests in real estate serving the healthcare industry in the United States. It currently has negative earnings. The Company’s portfolio consists of investments in various healthcare divisions: senior housing, post-acute/skilled nursing, life science, medical office and hospital.
HCP Company Profile
HCP, Inc. (HCP), incorporated on March 21, 1985, is a self-administered real estate investment trust (REIT). The Firm invests in real estate serving the healthcare industry in the United States. The Company’s portfolio consists of investments in various healthcare divisions: senior housing, post-acute/skilled nursing, life science, medical office and hospital. The Company’s portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. The Firm has interests in unconsolidated joint ventures representing approximately 30 properties primarily in its senior housing, life science and medical office divisions.
More news for HCP, Inc. (NYSE:HCP) were recently published by: Nasdaq.com, which released: “HCP Inc. (HCP) Q3 Earnings Preview: What’s in the Cards?” on October 31, 2016. Forbes.com‘s article titled: “HCP Crosses Above Average Analyst Target” and published on October 14, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.